BOSTON SCIENTIFIC CORP 8-K

What Happened
On July 29, 2026 Boston Scientific Corporation announced its financial results for the quarter ended June 30, 2026 and furnished a press release reporting those results with the SEC on Form 8-K (Item 2.02). The press release is included as Exhibit 99.1 to the filing; the cover page iXBRL tags are provided as Exhibit 104. The report was signed by Susan Thompson, Vice President, Chief Corporate Counsel and Assistant Secretary.

Key Details

• Filing date: July 29, 2026; quarter reported: Q2 ended June 30, 2026 (Item 2.02).
• Press release containing the quarterly results furnished as Exhibit 99.1.
• Cover page Inline XBRL tags included as Exhibit 104.
• Form 8-K signed by Susan Thompson on behalf of Boston Scientific.

Why It Matters
This 8-K officially notifies investors that Boston Scientific has released its quarterly results; the press release is the primary source for reported revenue, earnings, cash flow and any management commentary or outlook. Retail investors should review Exhibit 99.1 for the detailed numbers and any discussion of performance or guidance, and monitor subsequent filings (earnings slides, 10-Q) for more complete financial disclosures.